North America Influenza Vaccines Market Forecast to 2028, Pharmaceuticals

North America Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)

Report Code : BMIRE00026961 | Region : North America | Industry : Pharmaceuticals | Published Date : 10/Jan/2023

The North America influenza vaccines market is expected to grow from US$ 3,155.29 million in 2022 to US$ 4,909.00 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

Increase in Government Support to Promote Influenza Vaccination Boosts North America Influenza Vaccines Market

Several governments of North American countries are supporting the promotion of vaccination through multiple activities and programs. By 2022, enough vaccines have been secured to cover all risk groups eligible for a government-funded flu vaccine through the National Immunisation Program (NIP). A few more instances of government support for influenza vaccination include: In July 2022, Public Services and Procurement Minister Filomena Tassi and Health Minister Jean-Yves Duclos announced that the Government of Canada had signed a new contract with GlaxoSmithKline (GSK) to support a sustainable influenza pandemic readiness. The Government of Canada maintains pandemic influenza vaccine preparedness in the event of an influenza pandemic. It has had a contract with GSK to provide seasonal and pandemic influenza vaccines since 2001. Pandemic influenzas are unpredictable but occur when a new strain of influenza virus emerges, spreads widely, and causes the disease. In July 2022, Seniors and Long-term Care Minister Scott Johnston and Health Minister Audrey Gordon announced that the Manitoba government would expand the high-dose flu vaccine eligibility to include all adults aged 65 and over to ensure that more of the Manitoba population is protected against influenza. The Victorian government proposed a grant and reimbursement program to help GPs and pharmacies improve access and uptake of the influenza vaccines by June and July 2022. In September 2019, the former US President Donald Trump signed an executive order to promote the development of better vaccines against seasonal flu and the potential for pandemic flu outbreaks. In October 2021, the Provincial Government encouraged all Newfoundlanders and Labradorians to get a flu shot. From October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. Thus, increasing government support to promote the influenza vaccination is driving the North America influenza vaccines market.

North America Influenza Vaccines Market Overview

The North America influenza vaccines market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2022. The rising number of flu cases, growing research & development activities on flu vaccines, and increasing demand for advanced vaccines to prevent diseases are among the prominent factors propelling the market growth in this region.

North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

North America Influenza Vaccines Market Segmentation

The North America influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.

Based on vaccine type, the North America influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.

Based on virus type, the North America influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.

Based on technology, the North America influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.

Based on route of administration, the North America influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.

Based on target group, the North America influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.

Based on country, the North America influenza vaccines market is segmented into the US, Mexico, and Canada. The US dominated the market in 2022.

AstraZeneca; Emergent BioSolutions Inc.; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; Moderna, Inc.; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the North America influenza vaccines market.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Influenza Vaccines Market – By Vaccine Type

1.3.2 North America Influenza Vaccines Market – By Virus Type

1.3.3 North America Influenza Vaccines Market – By Technology

1.3.4 North America Influenza Vaccines Market – By Route of Administration

1.3.5 North America Influenza Vaccines Market – By Target Group

1.3.6 North America Influenza Vaccines Market – By Country

2. North America Influenza Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Influenza Vaccines Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.3 Experts Opinion

5. North America Influenza Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Government Support to Promote Influenza Vaccination

5.1.2 Increasing Investment by Top Market Players and Governments

5.2 Market Restraints

5.2.1 High Cost of Vaccine Development

5.3 Market Opportunities

5.3.1 Emerging Economies

5.4 Future Trends

5.4.1 Strong Pipeline Candidates for Influenza Vaccines

5.5 Impact Analysis

6. Influenza Vaccine Market –North America Analysis

6.1 North America Influenza Vaccines Market, By Country - Forecasts And Analysis

6.2 North America Influenza Vaccines Market Revenue Forecasts And Analysis – 2020- 2028 (US$ Mn)

6.2.1 North America: Influenza Vaccines Market, 2019–2028 (US$ Million)

7. North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type

7.1 Overview

7.2 North America Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)

7.2.1 North America: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

7.3 Quadrivalent Vaccines

7.3.1 Overview

7.3.2 Quadrivalent Vaccines : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Trivalent Vaccines

7.4.1 Overview

7.4.2 Trivalent Vaccines : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type

8.1 Overview

8.2 North America Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)

8.2.1 North America: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

8.3 Influenza Virus Type A

8.3.1 Overview

8.3.2 Influenza Virus Type A : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Influenza Virus Type B

8.4.1 Overview

8.4.2 Influenza Virus Type B : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9. North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology

9.1 Overview

9.2 North America Influenza Vaccines Market, By Technology 2022 & 2028 (%)

9.2.1 North America: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

9.3 Egg-based

9.3.1 Overview

9.3.2 Egg-based : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Cell-based

9.4.1 Overview

9.4.2 Cell-Based : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration

10.1 Overview

10.2 North America Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)

10.2.1 North America: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

10.3 Injection

10.3.1 Overview

10.3.2 Injection : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Nasal Spray

10.4.1 Overview

10.4.2 Nasal Spray: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group

11.1 Overview

11.2 North America Influenza Vaccines Market, By Target Group 2022 & 2028 (%)

11.2.1 North America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

11.3 Infants

11.3.1 Overview

11.3.2 Infants : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Children

11.4.1 Overview

11.4.2 Children: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Adults

11.5.1 Overview

11.5.2 Adults : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Elderly People

11.6.1 Overview

11.6.2 Elderly People: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. North America Influenza Vaccines Market Analysis and Forecasts To 2028 – Country Analysis

12.1 North America Influenza Vaccines Market Revenue and Forecasts To 2028

12.1.1 Overview

12.1.2 North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

12.1.2.1 US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.1 Overview

12.1.2.1.2 US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.3 US: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.1.4 US: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.1.5 US: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.1.6 US: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.1.7 US: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.2 Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.1 Overview

12.1.2.2.2 Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.3 Canada: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.2.4 Canada: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.2.5 Canada: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.2.6 Canada: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.2.7 Canada: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.3 Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.1 Overview

12.1.2.3.2 Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.3 Mexico: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.3.4 Mexico: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.3.5 Mexico: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.3.6 Mexico: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.3.7 Mexico: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

13. North America Influenza Vaccine Market –Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Moderna, Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 SEQIRUS

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sanofi

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 GlaxoSmithKline plc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Emergent BioSolutions Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Mitsubishi Chemical Group Corporation

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Serum Institute of India Pvt. Ltd

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 MYLAN N.V.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 AstraZeneca

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1. Below are a few instances of companies and their pipeline products:

Table 2. North America Influenza Vaccines Market– Revenue and Forecast to 2028 (USD Million)

Table 3. North America Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 6. North America Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 7. North America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 8. US Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 11. US Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 12. US Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 13. Canada Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 16. Canada Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 17. Canada Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 18. Mexico Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 22. Mexico Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 23. Recent Inorganic Growth Strategies in the Influenza Vaccine Market

Table 24. Recent Organic Growth Strategies in the Influenza Vaccine Market

Table 25. Glossary of Terms, Influenza Vaccines Market

LIST OF FIGURES.

Figure 1. North America Influenza Vaccines Market Segmentation

Figure 2. North America Influenza Vaccines Market Segmentation, by Country

Figure 3. North America Influenza Vaccines Market Overview

Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in North America Influenza Vaccines Market

Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. North America: PEST Analysis

Figure 7. Experts Opinion

Figure 8. North America Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 9. North America Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)

Figure 10. Quadrivalent Vaccines: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Trivalent Vaccines: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. North America Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)

Figure 13. Influenza Virus Type A : North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Influenza Virus Type B: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. North America Influenza Vaccines Market, by Technology 2022 & 2028 (%)

Figure 16. Egg-based: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Cell-Based: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. North America Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)

Figure 19. Injection: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Nasal Spray: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. North America Influenza Vaccines Market, by Target Group 2022 & 2028 (%)

Figure 22. Infants: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Children: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Adults: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Elderly People: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. North America: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)

Figure 27. North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

Figure 28. US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Growth Strategies in the Influenza Vaccine Market, 2021-2028

The List of Companies - North America Influenza Vaccines Market

● AstraZeneca

● Emergent BioSolutions Inc.

● GlaxoSmithKline plc.

● Mitsubishi Chemical Group Corporation

● Moderna, Inc.

● MYLAN N.V.

● Sanofi

● SEQIRUS

● Serum Institute of India Pvt. Ltd

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America influenza vaccines market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in North America influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Back to Industry Report

Pricing
	$3,000.00	Single User Price
	$4,000.00	Site Price
	$5,000.00	Enterprise Price
Buy Now

North America Influenza Vaccines Market Forecast to 2028

Have Additional Questions?